Gene · 10587
Papers1,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor-Treg crosstalk in castration-resistant prostate cancer. | Front Immunol | 2026 | 41710887 | PubTator, text mining | PubMed |
| The Effects of Aging and Anti-Aging Dietary Restriction on Brain Glutathione and Thioredoxin Redox Systems. | Aging Dis | 2026 | 41701881 | PubTator, text mining | PubMed |
| Digoxin Attenuates Ocular Hypertension and Protects Trabecular Meshwork Cells via Ferroptosis Inhibition. | Invest Ophthalmol Vis Sci | 2026 | 41563015 | PubTator, text mining | PubMed |
| Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy. | Redox Biol | 2026 | 41518849 | PubTator, text mining | PubMed |
| Imbalance of stem-like and effector T cell states in children with early type 1 diabetes across conventional and regulatory subsets. | Nat Commun | 2025 | 41381478 | PubTator, text mining | PubMed |
| Correction to "Targeted Co-Delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer". | Small | 2025 | 41163467 | PubTator, text mining | PubMed |
| Development of novel analogs of the TRi-1 and TRi-2 selenoprotein thioredoxin reductase inhibitors with initial assessment of their cytotoxicity profiles. | Free Radic Biol Med | 2025 | 40967346 | PubTator, text mining | PubMed |
| Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy. | bioRxiv | 2025 | 40964317 | PubTator, text mining | PubMed |
| Discriminative influence of persistent organic pollutants on nesting green sea turtles through genotoxicity, oxidative stress and reproductive related markers. | J Hazard Mater | 2025 | 40961700 | PubTator, text mining | PubMed |
| Towards Representing Change in the BFO. | Form Ontol Inf Syst | 2025 | 40949106 | PubTator, text mining | PubMed |
| Inherited, Non-CAH Primary Adrenal Insufficiency in Children: A Genetic and Clinical Profile from a Tertiary Care Centre. | Indian J Endocrinol Metab | 2025 | 40917321 | PubTator, text mining | PubMed |
| The methylation of TXNRD2 with chronic heart failure: the interaction effect between methylation regulation and clinical parameters-- a single center pilot study. | BMC Cardiovasc Disord | 2025 | 40841993 | PubTator, text mining | PubMed |
| Polymorphisms in Hg-related genes and their impact on mercury burden and oxidative stress biomarkers among riverside Amazonian populations. | Chemosphere | 2025 | 40840299 | PubTator, text mining | PubMed |
| LENG8 mediates RNA nuclear retention and degradation in eukaryotes. | bioRxiv | 2025 | 40832163 | PubTator, text mining | PubMed |
| Diagnostic performance of ACR-TIRADS for thyroid nodule risk stratification in pediatric patients. | Endocrine | 2025 | 40794379 | PubTator, text mining | PubMed |
| Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology. | Front Cell Dev Biol | 2025 | 40741332 | PubTator, text mining | PubMed |
| Case report and literature review: novel TXNRD2 compound heterozygous variants in familial glucocorticoid deficiency type 5. | Front Pediatr | 2025 | 40726908 | PubTator, text mining | PubMed |
| The Cytotoxic Effect on HepG2 Cell Line and In Vitro, In Silico Evaluation of 1,2,4-Triazine Compounds as Inhibitors of Acetylcholinesterase and Glutathione S-Transferase. | J Biochem Mol Toxicol | 2025 | 40702843 | PubTator, text mining | PubMed |
| Coenzyme A protects against ferroptosis via CoAlation of mitochondrial thioredoxin reductase. | J Clin Invest | 2025 | 40694424 | PubTator, text mining | PubMed |
| Sex-based immunological differences in multisystem inflammatory syndrome in children: potential role of TR3-56 cells for pathogenesis, diagnosis, and therapy. | Front Immunol | 2025 | 40621459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10587/papers?page=2